Amneal And Impax To Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Impax Laboratories (IPXL) PT Lowered to $17 at Cowen Following Announced Deal with Amneal
October 17, 2017 11:42 AM EDTCowen lowered its price target on Impax Laboratories (NASDAQ: IPXL) to $17.00 (from $20.00) while maintaining a Market Perform rating following the company's announced business combination with Amneal. This deal will allow them to become the 5th largest generic company in the U.S.
As a... More
